GH is necessary for the replication of subcutaneous adipose ceFls. It has also been shown that successful treatment of This study was undertaken to evaluate adipose cell size amd hygopjtuitary patients with WGH reduces skinfold number and subcutaneous fat and blosd lipids composition in the first months-Thereaftm, skinfold thickness hypopituitary ~a t i e n t s before and during treatment with. inGzeaa progressiveky and mturns to pretreatment values human growth hormone (BGH). The investigations were which E e att*ed aftm 4-5 y a r s of t h e~a p y (1, 26, 27, 32, performed in 14 prepubertal children 6-11 11/12 y e a s of 33). age, with idiopathic hypopituitarism. Human growth h o m a n e B~~~~~~ madjficatiolts d adipocfles explain the was administered successfully to 6 of these 14 patients for at changes in skhfold tkcknem observed dun;ng treatment with least 1 year.
B~~~~~~ madjficatiolts d
adipocfles explain the was administered successfully to 6 of these 14 patients for at changes in skhfold tkcknem observed dun;ng treatment with least 1 year.
HGH, this study was, under;t&en to emluate adipose cell size Before HGH treatment there was a significant reduction of and nmber and subcutme~pus fat and blood composi- adipose tissue cell number according to chronologic age and t o ti,n ini h y g o p i t~t w y p8ieIrEts before and dm.g skeletal age. The average adipose cell size was significantky HGH. larger than normal. A significant correlation between subcutaneous adipose cell mean-weight and tricipital and subscapular skinfold thickness, similar to that observed in normal children, was observed. The distribution of fatty acids in the subcutaneous fat and in the blood lipid composition was normal.
During the 1st and 2nd year of HGH treatment, the total number of adipose cells increased rapidly. There was also a highly significant reduction of the average adipose cell size after the 1st year. A significant reduction of the fatty acids unsaturated fraction was observed after the 1st year without further changes after the 2nd year of treatment. The blood lipid composition did not change significantly after either 1 or 2 years of HGH treatment.
Speculation
The striking increase in total number of adipose cells observed during HGH administration in hypopituitary patients tends to prove that the adipose tissue organogenesis is not limited to a finite period ending after the 1st year of life.
The modifications in composition of adipose tissue triglycerides induced by long term treatment with HGH would mean that the several components of the fatty acid pool are differentially liberated.
The importance of growth hormone (GH) for the multiplication of muscle, cartilage, or liver cells has been well established both in man and in animals (9) . Brook (7) has shown that at the end of intrauterine growth and during the first year of life, MATERIALS 
AND METHOID&

STJBJECTS
The investigations were performed int 14 prepubertal children, 10 boys and 4 girls, 6-1 7 11/12 years of age, with idiopathic hypopituitarism. Clinical data are su~nmarized in Table I . G r o u p I contains the hypopituitary subjects who have been treated subsequently with HGH, whereas group I1 consists of patients untreated SKI far. The standards used for height, weight, and height velocity were those of Tanner et al. (34) and standard deviation scores (SD) were calculated according to Tanner e t aL (33) . It should be remembered that in older patients, as in case MP, the SD can give a false figure because it must be compared wikh adolescent spurt velocities in the standards (33). Bone age was determined by comparison with the standards of Greulich and Pyle (16) .
In all cases, GH deficiency was docu~nented by the absence of GH release during at least two of the foIlowing tests:
intravenous insulin (0.1 IU/kg of body wieght) (29) , arginine infusion (0.5 g/kg body weight for 30 min) (24) , and intramuscular gluc.igon (0.1 rngjkg body wt] (36) . Associated hormonal deficiencies were investigated by measuring serum PBI and serum thyroxine; thyroid-stimulating hormone release was studied after intravenous injection of 200 yg synthetic thyrotropin-releasing hormone (23, 40) ; follicle-st~mulating and luteinizing hormone release was studied after intravenous injection of 25 yg synthetic Iuteinizing hormone-releasing hormone (19, 35, 40) except in cases DN, MP, and B V in whom these data are not yet available; pituitary adrenocortico-tropic hormone reserve was evaluated by the diurnal variation of cortisol in plasma, the response to insulin, and the metyrapone test (39) . One patient (HB) who had been treated previously with androgens needed cortisone replacement therapy. Cases RB and HB are siblings and were subjects of another report (18) . Case PD is a hypopituitary child of very tall parents (31) . Seven patients received appropriate individually adapted amounts of thyroid extract to remain euthyroid.
The tests were performed when the subjects were euthyroid for at least 6 months. HGH prepared according to the method of Raben (28) was administered successfully to 6 of these 14 patients. Cases AN, EG, and RR received 5 mg twice a week for 2 years. In the three other patients (MC, DN, and MP) 2.5 mg twice a week was administered for 1 year. The conversion of milligrams into international units is unknown. Table 2 represents some of the effects of HGH treatment in these cases.
LABORATORY METHODS
After having obtained informed consent from the patient's parents, subcutaneous adipose tissue samples were taken by biopsy from the left subscapular area (11) and blood was withdrawn for gas-liquid chromatography analysis of serum lipids. An adipose tissue fragment weighing 4-15 mg was treated by osmium tetroxide according to the method of Hirsch and Gallian (17) . The diameter of 200 adipocytes was measured microscopically. The variance of the cell diameter was calculated in each case. Mean cell volume was determined according to the method of Goldrick (15); mean fat cell weight was obtained assuming that the density of adipocyte triglycerides equals that of triolein (0.91 5) (17) .
Triglycerides extracted according to the method of Folch et a2. (14) from a second adipose tissue shred were submitted to an intermethylation reaction as described previously (3, 4). Negligible amounts of minor components were not taken into account for further calculation. Skinfold thickness was measured by the Harpenden skinfold caliper at the following sites: biceps, triceps, subscapular area, abdomen, and above the iliac crest (12) . The whole body fat was estimated from the tricipital and subscapular skinfold thickness according t o the method of Pariskova (25) . The total number of adipocytes was calculated from the body fat and the mean adipose cell weight. The results obtained in the hypopituitary patients have been compared with data collected previously in normal children and, when informative, in obese children of the same age (2) . Cell number has been related t o age. Because it is known that in normal children after 1 year of age adipocyte cell size from the subscapular area remains stable, age was not taken into account (2) .
Plasma GH was determined by radioimmunoassay with double antibody technique (30, 43) .
RESULTS
BEFORE HGH TREATMENT
Total Adipose Cell Number. Figure 1 represents the total subcutaneous adipocyte number in hypopituitary patients as related t o chronologic age-and t o bone age. There was a very significant (P < 0.001) reduction of adipose cell number according t o chronologic age and t o skeletal age.
Adipose cell size. Table 3 summarizes the mean diameter and mean cell weight of the adipose cells of 1 4 hypopituitary patients, of 44 normal children, and of 6 6 obese children. The average adipose cell size of the hypopituitary patients, although smaller than that of the obese subjects, was significantly larger than that of the control subjects. Figure 2 represents the relation between subcutaneous adipose cell mean weight and tricipital and subscapular skinfold thickness in the hypopituitary patients compared with the mean of 2 2 SD observed in normal children. A significant correlation, similar t o that observed in normal children, was seen.
Fatty Acids Distribution in Subcutaneous Fat and in Lipids in Blood. In Table 4 , the distribution of individual fatty acids in the adipose tissue triglycerides and of the free fatty acids in blood, triglycerides, phospholipids, and cholesterol esters of the hypopituitary patients is compared with that of normal children. The distribution of fatty acids in the subcutaneous fat was similar in both groups of children and the small differences observed in the blood lipid composition are, with a single exception (C1 : 2 ) , not significant.
AFTER HGH TREATMENT
Total Adipose Cell Number. As shown in Figure 3A , total adipose cell number in relation t o bone age increases rapidly in all cases except one subject ( A N ) during the 1st year of HGH treatment. As shown in Table 2 , this is also apparent from the changes in SD of total adipose cell number. During the 2nd ' Forty-four children of normal weight 2-14 years of age.
Sixty-six obese children 2-17 years of age. 3Average variance (s2) calculated from the variance of the individual cell size distribution curve obtained in each subject by measuring 200 adipose cells. Cholesterol esters in blood Fig. 3 . Total number of adipose cells as a function of bone age and triceps skinfold thickness, adipose cell mean weight, and body fat as a function of chronologic age and duration of human growth hormone treatment in six hypopituitary patients. Each patient is shown individually before ( 0 ) and after 1 ( 6 ) or 2 (a) years of treatment. TG: triglycerides. year of treatment this increase is maintained in patient EG, whereas, in t h e two remaining cases, it is less marked.
Skinfold Thickness and Adipose Cell Size. As shown in Table 5 and in Figure 3B , skinfold thickness is decreased'very significantly after the 1st year of treatment with HGH. The body fat mass calculated from t h e triceps and the subscapular skinfolds is reduced (Fig. 3C) . There is also a very significant reduction of t h e average adipose cell weight (Fig. 3 0 ) .
The effects of HGH after a 2nd year of treatment could only be studied in three cases: as shown i n Figure 3 , skinfold thickness has now increased in two out of three cases. The decrease of cell mean weight has leveled off in one case and is replaced b y a rise i n another one.
Fatty Acids Distribution in Subcutaneous Fat and in Lipids in Blood.
The distribution of fatty acids in the subcutaneous fat triglycerides before and after 1 year of HGH treatment is shown in Table 6 . A significant reduction of t h e unsaturated fatty acids a t the 5% level was observed. After t h e 2nd year of HGH administration, n o further changes were seen in t h e three cases studied. The lipid composition in blood did not change significantly after either 1 o r 2 years of HGH treatment.
DISCUSSION
Our data confirm that; as shown b y Brook (7, 8) , t h e number of subcutaneous adipose cells is abnormally low in hypopituitarism. This abnormality is most striking when adipocyte number is related t o chronologic age and bone age. Cell replication in adipose tissue apparently needs t h e presence of growth hormone. On t h e other hand, the average adipose cell size of the patients is larger than normal and is closely related to their tricipital skinfold thickness. The fat accumula- (2) . HGH treatment in hypopituitary patients is associated with a very significant decrease in the adipocyte cell size together with an increase in cell number. The net result is a significant decrease in skinfold thickness, as already shown by several authors (27, 33) . It is clear that lipolysis induced by exogeneous GH supersedes the effect of GH on adipocyte replication. In five out of six patients the increase in total number of adipose cells during the 1st year of treatment exceeded that observed during normal growth. This was contrary t o the recent study of Brook (8) , who found no increased multiplication rate after 6 months of treatment. This contradiction might be explained tentatively by the longer duration of treatment for our patients, and/or by the difference in site where subcutaneous adipose tissue biopsy was performed (1 1). In the briefly reported study of Knittle et al. (22) on adipose tissue cellularity in six cases of ateliotic dwarfism, the response to exogeneous HGH was more diverse than in our cases. Of the six patients treated for 8 months, only two showed an increase in number of adipose cells together with a decrease in cell size. In three subjects the number of adipose cells increased without changes in cell size. In only one subject was an increase in cell size observed. Knittle et al. (22) found different modifications in glucose tolerance before and after treatment and propose a link between the changes in glucose metabolism and adipocyte response after HGH in hypopituitarism. Our own material does not allow us to elaborate further on this matter. If catch-up growth does occur, one would have to admit that adipose tissue organogenesis is not limited to a finite period ending after the 1st year of life. However, it must be stressed that the estimation of total number of adipocyte cells is, at best, a very rough method.
Acute lipolysis induced by several agents including HGH is ' associated with a rise in the proportion of unsaturated fatty acids in free fatty acids in blood (3, 10, 20, 21, 37, 38) . It is still unclear whether this is caused by a higher rate of peripheral utilization and, concomitantly, an accelerated mobilization of the unsaturated fatty acids from the fat stores or, conversely, by a lower rate of peripheral utilization. In all our patients the proportion of unsaturated fatty acid in the adipose tissue was decreased after the 1st year of treatment without changes in the blood composition. This shows that, at least after lipolysis induced by repeated administration to exogenous HGH, it is the unsaturated fraction which is used peripherally.
SUMMARY
Subcutaneous fat and blood 'lipids were studied in 14 prepubertal children with idiopathic hypopituitarism. The investigations were repeated in six cases after 1 year and in three cases after 2 years of treatment with HGH.
Total number subcutaneous adipose cells in patients with hypopituitarism was significantly lower than in normal children. The administration of HGH induced a decrease in adipocyte size and an increase in cell number.
Before treatment, the distribution of individual fatty acids in the subcutaneous fat triglycerides and in the blood lipids did not differ from that of the normal children. After 1 year of HGH treatment, the fatty acids unsaturated fraction was decreased in the adipose tissue triglycerides, whereas it remained unchanged in the blood. No further modifications were observed after the 2nd year of treatment.
